Literature DB >> 3531426

Homoharringtonine--perspectives on an active new natural product.

P J O'Dwyer, S A King, D F Hoth, M Suffness, B Leyland-Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3531426     DOI： 10.1200/JCO.1986.4.10.1563

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 2.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

3.  Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro.

Authors:  J Cai; R Wei; X Ma; H Zhu; Y Li
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

Review 4.  Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approval.

Authors:  Hagop M Kantarjian; Susan O'Brien; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-20

5.  Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study.

Authors:  M A Runge-Morris; M S Kies; E Vokes; R Blough; L Weidner; R Knop; K Rowland
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

6.  Ester alkaloids from Cephalotaxus interfere with the 2'3'-cGAMP-induced type I interferon pathway in vitro.

Authors:  Gayoung Park; Sun Yeou Kim; Yoon-Jae Song
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.